Authorship note: ec and sl contributed equally to this work. conflict of interest: the university of strasbourg, inserm, the ihu strasbourg, and mount sinai hospital have filed a patent application on the clinical gene signature-based human cell culture model and uses thereof with yh and tfb as coinventors (wo 2016174130 a1), which has been licensed to alentis therapeutics, basel, switzerland

HIGHLIGHTS

• who: Emilie Crouchet and collaborators from the Universitu00e9University of, Boston, Massachusetts, USA have published the article: Authorship note: EC and SL contributed equally to this work. Conflict of interest: The University of Strasbourg, Inserm, the IHU Strasbourg, and Mount Sinai Hospital have filed a patent application on the clinical gene signature-based human cell culture model and uses thereof with YH and TFB as coinventors (WO 2016174130 A1), which has been licensed to Alentis Therapeutics, Basel, Switzerland, in the Journal: (JOURNAL)
• what: The authors aimed to explore ACE as a therapeutic target for HCC chemoprevention . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.